Skip to content

Clinical trials

Phase 3 Muscular Dystrophy, Duchenne trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Country / region: Israel Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20141
20162
20171
20182
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics3
Sarepta Therapeutics, Inc.3
Catabasis Pharmaceuticals1
GlaxoSmithKline1
Italfarmaco1
Kyntra Bio1
Pfizer1
Santhera Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne12
Muscular Dystrophies4
Musculoskeletal Diseases3
Neuromuscular Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Nervous System Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.